GCMAX
Price
$38.44
Change
+$0.04 (+0.10%)
Updated
Sep 5 closing price
Net Assets
1.11B
VIMAX
Price
$358.38
Change
-$0.51 (-0.14%)
Updated
Sep 5 closing price
Net Assets
199.16B
Interact to see
Advertisement

GCMAX vs VIMAX

Header iconGCMAX vs VIMAX Comparison
Open Charts GCMAX vs VIMAXBanner chart's image
Goldman Sachs Mid Cap Value A
Price$38.44
Change+$0.04 (+0.10%)
VolumeN/A
Net Assets1.11B
Vanguard Mid Cap Index Admiral
Price$358.38
Change-$0.51 (-0.14%)
VolumeN/A
Net Assets199.16B
GCMAX vs VIMAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GCMAX vs. VIMAX commentary
Sep 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GCMAX is a Buy and VIMAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIMAX has more cash in the bank: 199B vs. GCMAX (1.11B). VIMAX pays higher dividends than GCMAX: VIMAX (1.47) vs GCMAX (0.65). GCMAX was incepted earlier than VIMAX: GCMAX (28 years) vs VIMAX (24 years). GCMAX (1.20) is less costly to investors than VIMAX (0.05). GCMAX is a more actively managed with annual turnover of: 56.00 vs. VIMAX (16.00). GCMAX has a lower initial minimum investment than VIMAX: GCMAX (1000) vs VIMAX (3000). VIMAX annual gain was more profitable for investors over the last year : 15.04 vs. GCMAX (5.12). VIMAX return over 5 years is better than : 65.04 vs. GCMAX (25.83).
GCMAXVIMAXGCMAX / VIMAX
Total Expense Ratio1.190.052,380%
Annual Report Gross Expense Ratio1.200.052,400%
Fund Existence28 years24 years-
Gain YTD7.1959.70974%
Front Load6%N/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets1.11B199B1%
Annual Yield % from dividends0.651.4745%
Returns for 1 year5.1215.0434%
Returns for 3 years8.7541.0721%
Returns for 5 years25.8365.0440%
Returns for 10 years4.53141.103%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LIVE16.851.15
+7.29%
Live Ventures
ZD38.090.73
+1.95%
Ziff Davis
JAZZ129.501.48
+1.16%
Jazz Pharmaceuticals plc
CHSCP28.930.15
+0.52%
CHS
BCML29.93-0.14
-0.47%
BayCom Corp